Literature DB >> 1426056

Subcellular localization of bFGF in human retinal pigment epithelium in vitro.

H Ishigooka1, A E Aotaki-Keen, L M Hjelmeland.   

Abstract

Basic fibroblast growth factor is a polypeptide mitogen with potential biological roles in angiogenesis, differentiation, and the survival of neurons. To study the expression and subcellular distribution of basic fibroblast growth factor in human retinal pigment epithelium in vitro, affinity-purified antipeptide antibodies were generated against a 15 amino acid sequence in the amino-terminus of this growth factor. Analysis of the cross reactivity and specificity of the affinity-purified antibodies demonstrated no ability to recognize acidic fibroblast growth factor and the ability to label specifically the major known forms of basic fibroblast growth factor in whole-cell lysates of retinal pigment epithelium in vitro. Examination of paraformaldehyde- or glutaraldehyde-fixed pigment epithelium at the light and electron microscopic levels revealed prominent localization of basic fibroblast growth factor to the nucleus and nucleolus. In cells fixed with organic reagents, prominent cytoplasmic staining was noted in addition to the nuclear staining seen in aldehyde fixed cells. Investigation of subcellular fractions by Western blot analysis indicated cytosolic as well as nuclear localization of the basic fibroblast growth factor. These analyses, however, demonstrated that the higher molecular weight forms of basic fibroblast growth factor predominate in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426056     DOI: 10.1016/0014-4835(92)90184-t

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

1.  Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis.

Authors:  Andreas Stahl; Lilija Paschek; Gottfried Martin; Nicolas Feltgen; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-27       Impact factor: 3.117

2.  Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation.

Authors:  H G Blaauwgeers; G M Holtkamp; H Rutten; A N Witmer; P Koolwijk; T A Partanen; K Alitalo; M E Kroon; A Kijlstra; V W van Hinsbergh; R O Schlingemann
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  Increased expression of angiogenic growth factors in age-related maculopathy.

Authors:  M Kliffen; H S Sharma; C M Mooy; S Kerkvliet; P T de Jong
Journal:  Br J Ophthalmol       Date:  1997-02       Impact factor: 4.638

4.  Fibroblast growth factor-2 decreases hyperoxia-induced photoreceptor cell death in mice.

Authors:  H Yamada; E Yamada; A Ando; N Esumi; N Bora; J Saikia; C H Sung; D J Zack; P A Campochiaro
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

5.  Immunolocalization of basic fibroblast growth factor during wound repair in rat retina after laser photocoagulation.

Authors:  C Yamamoto; N Ogata; X Yi; K Takahashi; M Miyashiro; H Yamada; M Uyama; K Matsuzaki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-11       Impact factor: 3.117

6.  Detection of c-sis proto-oncogene transcripts by direct enzyme-labeled cDNA probes and in situ hybridization.

Authors:  J T McClintock; I J Chan; S R Thaker; A Katial; F E Taub; A E Aotaki-Keen; L M Hjelmeland
Journal:  In Vitro Cell Dev Biol       Date:  1992-02

7.  Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance.

Authors:  C Yiangou; J J Gomm; R C Coope; M Law; Y A Luqmani; S Shousha; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  The 9E3 protein: immunolocalization in vivo and evidence for multiple forms in culture.

Authors:  M Martins-Green; A Aotaki-Keen; L M Hjelmeland; M J Bissell
Journal:  J Cell Sci       Date:  1992-03       Impact factor: 5.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.